[go: up one dir, main page]

FI930934L - Tetrahydropyrimidinderivat - Google Patents

Tetrahydropyrimidinderivat Download PDF

Info

Publication number
FI930934L
FI930934L FI930934A FI930934A FI930934L FI 930934 L FI930934 L FI 930934L FI 930934 A FI930934 A FI 930934A FI 930934 A FI930934 A FI 930934A FI 930934 L FI930934 L FI 930934L
Authority
FI
Finland
Prior art keywords
tetrahydropyrimide
derivatives
tetrahydropyrimide derivatives
Prior art date
Application number
FI930934A
Other languages
English (en)
Other versions
FI930934A7 (fi
FI930934A0 (fi
Inventor
Ralf Plate
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of FI930934A0 publication Critical patent/FI930934A0/fi
Publication of FI930934A7 publication Critical patent/FI930934A7/fi
Publication of FI930934L publication Critical patent/FI930934L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/12Nitrogen atoms not forming part of a nitro radical
    • C07D239/14Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI930934A 1992-03-04 1993-03-03 Tetrahydropyrimidinderivat FI930934L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92200622 1992-03-04

Publications (3)

Publication Number Publication Date
FI930934A0 FI930934A0 (fi) 1993-03-03
FI930934A7 FI930934A7 (fi) 1993-09-05
FI930934L true FI930934L (fi) 1993-09-05

Family

ID=8210467

Family Applications (1)

Application Number Title Priority Date Filing Date
FI930934A FI930934L (fi) 1992-03-04 1993-03-03 Tetrahydropyrimidinderivat

Country Status (11)

Country Link
US (1) US5470856A (fi)
EP (1) EP0559279A1 (fi)
JP (1) JPH05339245A (fi)
KR (1) KR930019640A (fi)
AU (1) AU661107B2 (fi)
CA (1) CA2090170A1 (fi)
FI (1) FI930934L (fi)
MX (1) MX9301178A (fi)
NO (1) NO930776L (fi)
NZ (1) NZ247037A (fi)
ZA (1) ZA931109B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19612504C2 (de) * 1996-03-29 2003-10-23 Boehringer Ingelheim Kg Neue Wirkstoffkompositionen
DE69804273T2 (de) * 1997-07-18 2002-10-31 F. Hoffmann-La Roche Ag, Basel 5h-Thiazolo[3,2-a]pyrimidinderivate
WO2011085406A1 (en) * 2010-01-11 2011-07-14 Mithridion, Inc. Compounds and compositions for cognition-enhancement, methods of making, and methods of treating
WO2012033956A1 (en) 2010-09-08 2012-03-15 Mithridion, Inc. Cognition enhancing compounds and compositions, methods of making, and methods of treating

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786648A (en) * 1986-12-08 1988-11-22 Warner-Lambert Company O-substituted tetrahydropyridine oxime cholinergic agents
IT1231237B (it) * 1987-09-21 1991-11-26 Angeli Inst Spa Derivati eterociclici
IL97266A0 (en) * 1990-03-06 1992-05-25 Warner Lambert Co Azabicyclo and azacyclo oximes and amines,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
NO930776L (no) 1993-09-06
AU661107B2 (en) 1995-07-13
NO930776D0 (no) 1993-03-03
FI930934A7 (fi) 1993-09-05
JPH05339245A (ja) 1993-12-21
EP0559279A1 (en) 1993-09-08
FI930934A0 (fi) 1993-03-03
MX9301178A (es) 1993-09-01
AU3393293A (en) 1993-09-09
KR930019640A (ko) 1993-10-18
ZA931109B (en) 1993-09-22
US5470856A (en) 1995-11-28
CA2090170A1 (en) 1993-09-05
NZ247037A (en) 1995-10-26

Similar Documents

Publication Publication Date Title
FI930208L (fi) Kinazolinderivat
FI935431A7 (fi) Kiantsoliinijohdannaisia
FI980341A7 (fi) 2-oksi-indolijohdannaisia
ATA75293A (de) Indolderivate
FI933037A7 (fi) Tiazolylvinylfenylderivat
FI941423A7 (fi) 17beta-substituoidut 4-atsa-5alfa-androstan-3-onijohdannaiset
DE69208877D1 (de) Chinuclidinderivate
FI924160A7 (fi) Benzanilidderivat
FI935726A7 (fi) Atsanorbornaanijohdannaisia
FI924159L (fi) Benzanilidderivat
NO922182D0 (no) Krystallinske oksatiolan-derivater
FI943976A7 (fi) 5-aryyli-indolijohdannaiset
DE69330497D1 (de) Chinazolin-derivate
FI925763L (fi) Fungicida 2-imidazolin-5-on- och 2-imidazolin-5-tionderivat
FI923726L (fi) Sulfaterade glykosaminoglykanoidderivat
FI20010214L (fi) Asyyliaminoindolijohdannaisia
DE59308714D1 (de) Cyclobutan-benzol-derivate
FI20002460A7 (fi) 4-difenyylimetyylipiperidiinijohdannaisia
FI942444A7 (fi) Terahydropyraanijohdannaisia
FI943885L (fi) Penaami-johdannaiset
FI935243L (fi) Pyridonkarboxylsyraderivat
FI944044L (fi) Fenyylialkanoliamiinijohdannaiset
FI920394A7 (fi) 3-kinuklidiinijohdannaiset
NO952288D0 (no) Benzazepinon-derivater
DE69313890D1 (de) 5-Aminoflavon-Derivate

Legal Events

Date Code Title Description
FD Application lapsed